Evidence map›Paper›PMID 34069831›Full record

ReviewCells2021

To Ubiquitinate or Not to Ubiquitinate: TRIM17 in Cell Life and Death.

Meenakshi Basu-Shrivastava, Alina Kozoriz, Solange Desagher, Iréna Lassot

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Multifaceted role ofMedComm · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Meenakshi Basu-ShrivastavaInstitut de Génétique Moléculaire de Montpellier, University Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-3992-4684
Alina KozorizInstitut de Génétique Moléculaire de Montpellier, University Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-7937-3701
Solange DesagherInstitut de Génétique Moléculaire de Montpellier, University Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-3735-7527
Iréna LassotInstitut de Génétique Moléculaire de Montpellier, University Montpellier, CNRS, Montpellier, France.ORCID 0000-0001-7059-7963
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TRIM17 is a member of the TRIM family, a large class of RING-containing E3 ubiquitin-ligases. It is expressed at low levels in adult tissues, except in testis and in some brain regions. However, it can be highly induced in stress conditions which makes it a putative stress sensor required for the triggering of key cellular responses. As most TRIM members, TRIM17 can act as an E3 ubiquitin-ligase and promote the degradation by the proteasome of substrates such as the antiapoptotic protein MCL1. Intriguingly, TRIM17 can also prevent the ubiquitination of other proteins and stabilize them, by binding to other TRIM proteins and inhibiting their E3 ubiquitin-ligase activity. This duality of action confers several pivotal roles to TRIM17 in crucial cellular processes such as apoptosis, autophagy or cell division, but also in pathological conditions as diverse as Parkinson's disease or cancer. Here, in addition to recent data that endorse this duality, we review what is currently known from public databases and the literature about

Indexed as

UbiquitinationAnimalsCell DeathCell SurvivalEnzyme StabilityHumansProtein StabilityProteolysisSignal TransductionTripartite Motif ProteinsUbiquitinated ProteinsUbiquitin-Protein LigasesTRIM17 protein, humanTripartite Motif ProteinsUbiquitinated ProteinsUbiquitin-Protein LigasesapoptosisautismautophagycancermitosisParkinson’s diseaseproteolysisTRIM17ubiquitination

Identifiers

PMID34069831
PMCPMC8157266
OpenAlexW3163249734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.